FDA Inspection
AnaptysBioFDA Inspection 1315526 - AnaptysBio - April 29, 2026
Discuss this record with AI
Record Details
This FDA Inspection record concerns AnaptysBio, with an inspection on April 29, 2026, issued by the Los Angeles District Office, covering human drugs.
Open in Dashboard
ID · 97589b7c-1fe1-4a22-af67-9c1f29711d4d
Violation Codes1
21 CFR 312.50
Full citation text and observation details available on the Dashboard.